ST. LOUIS, Oct. 3, 2019 /PRNewswire/ -- BacterioScan, Inc., a St. Louis-based rapid diagnostic device company, has been selected to present advances on its in vitro diagnostic platform at IDWeek 2019.
*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. BioSTL logo BioSTL's nonprofit investment arm has joined in the latest round of funding for diagnostic startup BacterioScan. The ...
In vitro diagnostics outfit BacterioScan closed an oversubscribed Series A financing round to support development of its next-generation, rapid diagnostic test for urinary tract infection (UTI). The ...
In this handout photo, a gloved hand loading a clinical sample into the BacterioScan Inc. instrument's disposable sample container. The BacterioScan Inc. instrument (Model 216 Dx) is shown in the ...
The way we diagnose urinary tract infections is still pretty belabored. The most common method is examining a urine sample for errant bacteria or blood cells. Other methods include a urine sample and ...
Creating a quicker, cheaper and more accurate way for doctors to test patients for urinary tract infections has netted a St. Louis startup at least $2 million in its latest round of fundraising.
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. St. Louis-based BacterioScan Inc., is in the middle of a $6 ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Laser technology developed by St. Louis startup ...
Bacterioscan has received approval from the U.S. Food and Drug Administration for its device that can quickly detect urinary tract infections. Samantha Liss • 314-340-8017 @samanthann on Twitter sliss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results